DrugPatentWatch Database Preview
Drugs in Development Information for Phosphoric acid
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Phosphoric acid?
Phosphoric acid is an investigational drug.
There have been 6 clinical trials for Phosphoric acid.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2011.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Tooth Abrasion, and Gingival Recession. The leading clinical trial sponsors are CrystalGenomics, Inc., CSPC-NBP Pharmaceutical Co., Ltd., and Universidade Estadual Paulista Júlio de Mesquita Filho.
There is one US patent protecting this investigational drug and twelve international patents.
Summary for Phosphoric acid
| US Patents | 1,025 |
| International Patents | 12,274 |
| US Patent Applications | 1,089 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2011-07-01) |
| Vendors | 41 |
Recent Clinical Trials for Phosphoric acid
| Title | Sponsor | Phase |
|---|---|---|
| Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion. | Fundação de Amparo à Pesquisa do Estado de São Paulo | N/A |
| Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion. | Universidade Estadual Paulista Júlio de Mesquita Filho | N/A |
| Effect of Curodont Repair on Color Change of White Spot Lesions | Cairo University | Phase 2 |
Clinical Trial Summary for Phosphoric acid
Top disease conditions for Phosphoric acid
Top clinical trial sponsors for Phosphoric acid
US Patents for Phosphoric acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Phosphoric acid | Start Trial | Colloidal sols of antimony pentoxide in an aqueous medium and their preparation | Laurel Industries, Inc. (Cleveland, OH) | Start Trial |
| Phosphoric acid | Start Trial | Unique bone regeneration tricalcium phosphate | The United States of America as represented by the Secretary of the Army (Washington, DC) | Start Trial |
| Phosphoric acid | Start Trial | Imidazole ether compounds | San-Apro Limited (Tokyo, JP) | Start Trial |
| Phosphoric acid | Start Trial | Process of preparing non-cyclic polyalkylenepolyamines employing group VB metal catalysts | The Dow Chemical Company (Midland, MI) | Start Trial |
| Phosphoric acid | Start Trial | Drug delivery devices | Vipont Pharmaceutical, Inc. (Fort Collins, CO) | Start Trial |
| Phosphoric acid | Start Trial | Substituted propane-phosphinic acid compounds | Ciba-Geigy Corporation (Ardsley, NY) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Phosphoric acid
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Phosphoric acid | Canada | 1099610 | 1995-08-18 | Start Trial |
| Phosphoric acid | Germany | 2637185 | 1995-08-18 | Start Trial |
| Phosphoric acid | France | 2321324 | 1995-08-18 | Start Trial |
| Phosphoric acid | United Kingdom | 1563214 | 1995-08-18 | Start Trial |
| Phosphoric acid | Italy | 1065149 | 1995-08-18 | Start Trial |
| Phosphoric acid | Japan | S5229499 | 1995-08-18 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
